CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...

This edition of Market Factors provides top stock picks in health care, a sector that has historically combined high profit ...

Other health insurers in the S&P 500, including Humana, Molina Healthcare and Cigna, saw their stock prices decline. Companies in the broader healthcare space, including Elevance Health, Centene and ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

45+ Medicare companies and brands analyzed by our team of experts. 30+ years of combined experience covering Medicare and personal finance. Governed by NerdWallet's strict guidelines for editorial ...

After Q1 earnings in 2024, CVS stock tanked from $80 to $55 per share, as the company missed its earnings target by a wide margin, and the full-year adjusted earnings target was lowered to $7 per ...

CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound will be ...

Overall, CVS Health booked adjusted earnings of $2.25 per share as the company’s profit soared 60 percent to $1.78 billion in the year’s first quarter. Total revenue climbed 7 percent to $94. ...

CVS Q1 adjusted EPS rose to $2.25 from $1.31, beating estimates, with adjusted operating income up 54.9% to $4.58 billion. Health Care Benefits revenue rose 8% to $34.81 billion; Medical benefit ...